Pr Eric Gilson will step down as IRCAN director on the 1st of January 2023. The next director will be an internationally recognized scientist. She/he will define an ambitious scientific strategy for IRCAN in the field of aging and cancer, both at national and international levels; she/he will play a major management role and will make decisions, assisted by an external Scientific Advisory Board and the Laboratory council of IRCAN, regarding team recruitment, scientific policy and budget.
In addition to her/his director position, the recruited scientist will run an ambitious research program in the field of aging and cancer, with no particular thematic required. Appropriate laboratory space will be available to the selected scientist.
The candidates must meet criteria to compete for national and international research funding; those who do not have a permanent position in France will have to apply to the ERC and/or to French institutional research/teaching positions (CNRS, INSERM, UCA). As a seeding funding, there is the possibility to apply for a chair of excellence (Labex Signalife) with a starting package and PI salary for one year.
Her/his mission will start on the 1st of January 2021 in order to prepare the next 2023-2027 5-year term contract of IRCAN.
Junior group leader
The IRCAN will provide appropriate laboratory space to a junior team leader willing to develop an outstanding and original project on aging and cancer; no particular thematic is required. The candidates must meet criteria to compete for national and international research funding; those who do not have a permanent position in France will have to apply to the ERC and/or ATIP/Avenir programs, and/or to French institutional research/teaching positions (CNRS, INSERM, UCA).
Applications should include a CV, a motivation letter, a 2-page research program summary, a list of publications and patent applications, clinical and/or teaching experience, awards and grants. They should be sent to Eric Gilson and Carole Hoffert-Nicolaï before the 1st of May, 2020.